HeartVista
HeartVista, now DBA Vista AI, is a privately held, FDA 510(k)-cleared medical imaging AI software company that automates cardiac MRI acquisition for hospital radiology departments and imaging centers using real-time computer vision, enabling faster, more consistent scans across sites and operators.
- Company typePrivate
- Founded2012
- HeadquartersPalo Alto, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What HeartVista does
HeartVista, Inc., now doing business as Vista AI, is a privately held medical imaging AI software company founded in 2012 and headquartered at 702 Marshall St, Suite 280, Redwood City, California. The company builds Vista AI Scan, an FDA 510(k)-cleared software platform that automates cardiac MRI acquisition. The product uses computer vision and process-automation AI to analyze MRI images in real time, guide technologists through scan positioning and parameter selection, and enforce consistent image quality across operators and sites, enabling non-specialist technologists to perform high-quality cardiac MRI exams. The platform is designed to interoperate with MRI scanners from multiple manufacturers, including GE Healthcare and Siemens.
Vista AI sells into hospital radiology departments and imaging centers facing rising imaging demand, technologist staffing shortages, and growing clinical complexity. Its primary customer segment is enterprise health systems; publicly named deployments include Stanford, Brigham and Women's Hospital, Sutter Health, and Radiology Regional. GTM is a direct enterprise field-sales motion with a "Book Demo" funnel, supplemented by clinical case studies, a content/resource hub, newsroom PR, and corporate LinkedIn and X channels. Revenue is generated via subscription / recurring software licensing of the FDA-cleared platform to healthcare providers, with pricing not publicly disclosed.
The company is venture-backed and pre-IPO, and reported headcount of 11–50 employees. In March 2024 it appointed MedTech veteran Daniel Hawkins as CEO and in September 2023 added Steve Cashman to its board. December 2024 publication of two-year clinical data — 26% faster CMR scan times, 50% more scan slots, and a 28-day-to-1-day backlog reduction — anchors the commercial value proposition. The company has signaled plans to extend the automation architecture beyond cardiac MRI into additional anatomies, broadening the addressable procedure footprint of the platform.
HeartVista firmographics
Firmographics- Name
- HeartVista
- Legal name
- Vista AI, Inc.
- Website
- https://heartvista.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- HeartVista, now DBA Vista AI, is a privately held, FDA 510(k)-cleared medical imaging AI software company that automates cardiac MRI acquisition for hospital radiology departments and imaging centers using real-time computer vision, enabling faster, more consistent scans across sites and operators.
- Ownership category
- akta.pro rank
HeartVista industry classification
Industry- Product category
- Medical Imaging Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Medical Imaging AI (HDAAAEAH), Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear) (HLAKABAE)
Keywords
Where HeartVista is headquartered
LocationHeadquarters
- HQ city
- Palo Alto
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
HeartVista business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations
Revenue model
- Software Licensing: FDA-cleared AI software licensing model where healthcare systems pay for access to Vista AI Scan technology to enable automated MRI scanning capabilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
HeartVista product offering
Product offeringCore offering
HeartVista (operating as Vista AI, Inc.) develops and licenses Vista AI Scan, an FDA-cleared AI-powered automated MRI acquisition software that performs and guides cardiac MRI scanning. The product enables any technologist at any site to deliver consistent, reproducible, high-quality cardiac MRI exams without requiring specialist radiology expertise, and is sold as enterprise software to hospitals, health systems, and imaging centers using MRI scanners from manufacturers such as GE Healthcare and Siemens.
Product overview
Vista AI offers a single unified product: Vista AI Scan, an FDA-cleared AI-powered MRI acquisition software. The platform automates cardiac MRI scanning, enabling healthcare systems to deploy consistent, high-quality cardiac imaging across all their sites without requiring specialist radiologists. The company is expanding its automation platform to other anatomies beyond cardiac MRI.
Differentiator
Problem solved
Functional benefit
Brands
- Vista AI Scan: FDA-cleared automated cardiac MRI scanning software that enables existing staff to deliver consistent, high-quality imaging across sites of service.
Products and services
- Vista AI Scan FDA-cleared AI-powered automated MRI acquisition software that enables any technologist to perform high-quality cardiac MRI scans at any site. The software automates scan positioning, parameter optimization, and quality assurance, reducing dependency on specialized radiology expertise and delivering consistent, reproducible results across operators, sites, and MRI scanner manufacturers (GE Healthcare, Siemens). It is sold to hospital radiology departments, integrated delivery networks, and imaging centers.
Quantifiable outcome
- 26% faster CMR scan times
- +2 more outcomes
Companies that use HeartVista
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
HeartVista technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature1 record
HeartVista partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights5 records
HeartVista competitors and assessment
Company assessmentDirect peers
- Subtle Medical: Subtle Medical develops AI-powered software that accelerates MRI scan times and improves image quality, directly overlapping with Vista AI Scan's core value proposition of faster, more accessible MRI. Both companies target radiology departments seeking workflow efficiency gains.
- Aidoc: Aidoc is a leading AI radiology platform offering workflow triage and diagnostic AI across multiple modalities. While broader in scope than Vista, it competes for the same hospital radiology AI budget and procurement slots.
- RapidAI: RapidAI provides AI-driven imaging analysis initially focused on stroke and now expanded across neuro, cardiac, and vascular workflows. It is a direct enterprise competitor for cardiac and complex imaging AI budgets at hospital systems.
- Arterys: Arterys (now part of Tempus) pioneered cloud-based AI cardiac MRI analysis, making it historically one of the most directly comparable companies to HeartVista's cardiac MRI focus.
- icometrix: icometrix develops AI solutions for brain MRI quantification and is FDA-cleared, with a similar model of selling AI imaging software to hospital radiology departments for specialized quantitative analysis.
Broad incumbents
- GE Healthcare: GE Healthcare manufactures MRI scanners and offers its own AI-based acceleration (AIR Recon DL) and broader Edison AI platform. It is simultaneously a partner and a major competitive incumbent that controls the scanner ecosystem in which Vista AI integrates.
- Siemens Healthineers: Siemens Healthineers manufactures MRI scanners and ships AI imaging tools (e.g., Deep Resolve, AI-Rad Companion). As both a Vista partner and a deep-pocketed incumbent, it is the principal ecosystem gatekeeper in the European and global MRI market.
- Philips Healthcare: Philips is a global MRI manufacturer with a growing AI portfolio (IntelliSpace AI). It competes with Vista for AI imaging budgets and could develop or acquire equivalent acquisition-automation functionality.
Emerging players
- Annalise.ai: Annalise.ai offers a comprehensive AI radiology decision-support platform covering chest X-ray, CT, and other modalities. It competes for the same radiology AI purchasing budgets and offers a broader multi-modality value proposition.
- Quibim: Quibim provides AI-powered medical imaging analysis with a focus on MRI biomarkers and quantitative imaging. It targets similar radiology AI use cases in oncology and other specialties, representing an emerging alternative for hospital AI deployments.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights6 records
Customer concentration
HeartVista social profiles
Digital presenceHeartVista financial estimates
Financial estimateRevenue estimate
Valuation estimate
HeartVista leadership team
Management profileNumber of profiles
Profiles2 records
HeartVista funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HeartVista M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HeartVista
What does HeartVista do?
HeartVista (operating as Vista AI, Inc.) develops and licenses Vista AI Scan, an FDA-cleared AI-powered automated MRI acquisition software that performs and guides cardiac MRI scanning. The product enables any technologist at any site to deliver consistent, reproducible, high-quality cardiac MRI exams without requiring specialist radiology expertise, and is sold as enterprise software to hospitals, health systems, and imaging centers using MRI scanners from manufacturers such as GE Healthcare and Siemens.
Is HeartVista a public or private company?
HeartVista is a private company. It is classified as venture growth investor backed and is currently operating.
When was HeartVista founded?
HeartVista was founded in 2012. It employs 11 to 50 people.
Where is HeartVista based?
HeartVista is headquartered in Palo Alto, United States, in the North America region.
How does HeartVista make money?
One revenue line is on record: software Licensing.
Who are HeartVista's main competitors?
Direct peers on record are Subtle Medical, Aidoc, RapidAI, Arterys and icometrix. Broad incumbents are GE Healthcare, Siemens Healthineers and Philips Healthcare. Emerging players are Annalise.ai and Quibim.
Does HeartVista have an API?
No public API is recorded for HeartVista.
What industry is HeartVista in?
HeartVista's product category is Medical Imaging Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 334510 and its SIC code is 3841.